Spotlight on Alzheimer's Disease
More than 6 million Americans are currently living with Alzheimer's, and that number is only expected to increase. In fact, estimates now show that this number could rise to nearly 13 million by 2050.
To help optimize the care of patients living with this debilitating condition, Spotlight on Alzheimer’s Disease features leading neurologists and other allied healthcare professionals sharing their insights on the latest diagnostic and treatment advances.
Episodes 1-15 of 22
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiersBeyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiersPreventing Alzheimer’s Disease Through Lifestyle Interventions
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiersAmyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
NeuroFrontiersResearching the Overlap: Hepatic Encephalopathy and Dementia in Focus
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
NeuroFrontiersThe Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
NeuroFrontiersHow DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
Public Health Disparities in Alzheimer's Disease and Brain Health
NeuroFrontiersPublic Health Disparities in Alzheimer's Disease and Brain Health
How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
NeuroFrontiersHow Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors
Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
NeuroFrontiersToxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
Examining the Role of Toxic Tau Proteins in Alzheimer's Disease
NeuroFrontiersExamining the Role of Toxic Tau Proteins in Alzheimer's Disease
PBA Treatment May Reverse Signs of Alzheimer’s Disease
NeuroFrontiersPBA Treatment May Reverse Signs of Alzheimer’s Disease
Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
NeuroFrontiersAlzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
NeuroFrontiersDiagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
Exploring Alzheimer’s Disease Risk Loci: 75 & Counting
NeuroFrontiersExploring Alzheimer’s Disease Risk Loci: 75 & Counting
Olive Oil: The Secret Ingredient Preventing Alzheimer's Disease?
Primary Care TodayOlive Oil: The Secret Ingredient Preventing Alzheimer's Disease?
